DE3689622T2 - Impfstoffe gegen menschliche respiratorische viren. - Google Patents

Impfstoffe gegen menschliche respiratorische viren.

Info

Publication number
DE3689622T2
DE3689622T2 DE3689622T DE3689622T DE3689622T2 DE 3689622 T2 DE3689622 T2 DE 3689622T2 DE 3689622 T DE3689622 T DE 3689622T DE 3689622 T DE3689622 T DE 3689622T DE 3689622 T2 DE3689622 T2 DE 3689622T2
Authority
DE
Germany
Prior art keywords
against human
proteins
human respiratory
vaccines
vaccines against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3689622T
Other languages
English (en)
Other versions
DE3689622D1 (de
Inventor
Gail Wertz
Peter Collins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Application granted granted Critical
Publication of DE3689622D1 publication Critical patent/DE3689622D1/de
Publication of DE3689622T2 publication Critical patent/DE3689622T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE3689622T 1986-01-14 1986-12-23 Impfstoffe gegen menschliche respiratorische viren. Expired - Lifetime DE3689622T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81874086A 1986-01-14 1986-01-14
PCT/US1986/002756 WO1987004185A1 (en) 1986-01-14 1986-12-23 Vaccines for human respiratory virus

Publications (2)

Publication Number Publication Date
DE3689622D1 DE3689622D1 (de) 1994-03-17
DE3689622T2 true DE3689622T2 (de) 1994-06-16

Family

ID=25226293

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3689622T Expired - Lifetime DE3689622T2 (de) 1986-01-14 1986-12-23 Impfstoffe gegen menschliche respiratorische viren.

Country Status (7)

Country Link
EP (1) EP0290446B1 (de)
JP (2) JPH01501357A (de)
AT (1) ATE101200T1 (de)
AU (1) AU605476B2 (de)
DE (1) DE3689622T2 (de)
HK (1) HK51597A (de)
WO (1) WO1987004185A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639853A (en) * 1987-09-29 1997-06-17 Praxis Biologics, Inc. Respiratory syncytial virus vaccines
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
AU2715288A (en) * 1987-11-20 1989-06-14 Upjohn Company, The Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
DE3878468T2 (de) * 1987-12-23 1993-06-09 Upjohn Co Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
CA2087853A1 (en) * 1990-07-24 1992-01-25 Gail W. Wertz Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
US6730305B1 (en) 2000-05-08 2004-05-04 The Uab Research Foundation Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
TW275632B (de) * 1992-04-21 1996-05-11 American Cyanamid Co
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
FR2726576B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US20020136739A1 (en) * 1996-07-12 2002-09-26 Cates George A. Subunit respiratory syncytial virus preparation
DE69720024D1 (de) * 1996-07-12 2003-04-24 Aventis Pasteur Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten
CA2417274A1 (en) * 2000-07-31 2002-02-07 Aventis Pasteur Limited Respiratory syncytial virus vaccines
FR2827605B1 (fr) 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
WO2012103361A1 (en) 2011-01-26 2012-08-02 Novartis Ag Rsv immunization regimen
EP3630173A1 (de) * 2017-05-29 2020-04-08 The United States of America, as represented by the Secretary, Department of Health and Human Services Rekombinantes chimäres bovines/humanes parainfluenzavirus 3, das rsv g exprimiert, und seine verwendung

Also Published As

Publication number Publication date
WO1987004185A1 (en) 1987-07-16
ATE101200T1 (de) 1994-02-15
EP0290446A1 (de) 1988-11-17
AU605476B2 (en) 1991-01-17
JPH08173171A (ja) 1996-07-09
EP0290446B1 (de) 1994-02-02
AU6941287A (en) 1987-07-28
DE3689622D1 (de) 1994-03-17
HK51597A (en) 1997-04-25
JPH01501357A (ja) 1989-05-18

Similar Documents

Publication Publication Date Title
DE3689622T2 (de) Impfstoffe gegen menschliche respiratorische viren.
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
NO20013701L (no) HER-2/neu-fusjonsproteiner
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
KR950700756A (ko) 바이러스성 질병 및 악성종양의 치료를 위한, 생바이러스(live virus)를 함유하는 백신(VACCINE CONTAINING LIVE VIRUSES FOR THERAPY OF VIRAL DISEASES AND MALIGNANCIES)
NO975730L (no) Metode for ökning av beskyttende immunresponser
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
SE8700466D0 (sv) Vaccines against melanoma
ATE126702T1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition